Arasani, Analita A.
HRN: 12-01-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
METRONIDAZOLE 500MG (TAB)
12/01/2025
12/07/2025
PO
500 MG
Q 8 HOURS
TMSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes